Month: March 2026

What if treating BPH didn’t mean risking sexual function? Seventeen studies now back Transperineal Laser Ablation – a minimally invasive approach that reduces troublesome urinary symptoms while preserving ejaculatory and erectile health. Discover how this technique is reshaping relief for men dealing with prostate enlargement. keep reading

Prostate cancer patients benefit from personalized exercise plans, including resistance training, aerobic activity, and high-intensity intervals. Each type of exercise brings unique advantages—supporting strength, cardiovascular health, recovery, and overall well-being. keep reading

Multifocality has shaped prostate cancer treatment for years, but research shows some cases are unifocal and may qualify for less invasive focal therapy. Careful clinical evaluation is key to tailoring the best treatment approach. keep reading

Evidence shows that lifestyle changes like plant-based eating, regular activity, and stress management can influence prostate cancer outcomes and even affect gene expression. Studies indicate these habits may slow disease progression and offer additional health benefits. keep reading

Recent studies highlight a decline in male fertility, potentially linked to chemical exposure and lifestyle factors. At the same time, new male birth control methods are advancing in clinical trials, signaling a shift in reproductive health options. keep reading

Imagine getting a fast answer to a medical question from a chatbot, only to realize it might miss the nuances of your unique situation. As AI tools like ChatGPT become more common in healthcare, concerns about privacy, accuracy, and personal connection remind us that experienced doctors still bring something irreplaceable to the table. keep reading

Focal therapy gives men with localized prostate cancer an appealing option—effective control with fewer side effects. Discover who qualifies for focal treatment, how it compares to radical approaches and Active Surveillance, and why specialized diagnosis is essential. keep reading

Traditional PSA screening can lead to overdetection and unnecessary biopsies due to its lack of specificity for prostate cancer. New research highlights biparametric MRI as a promising, quicker, and potentially more accurate first-line screening tool. keep reading